Fecal Calprotectin in Patients Infected with Intestinal Protozoan Infections
NCT06890455 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-03-24
Summary
Calprotectin extracted from stool can be detected easily using ELISA. Numerous studies have shown that fecal calprotectin concentrations demonstrate a good correlation with intestinal inflammation This study aims to detect the relationship between fecal calprotectin and Blastocystis hominis and Entamoeba histolytica infections.
Conditions
- Fecal Calprotectin in Intestinal Protozoa
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-31
- Primary Completion
- 2025-10-31
- Completion
- 2026-02-28
Countries
- Egypt
Study Locations
More Related Trials
-
Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide
NCT02977897 ·Status: UNKNOWN
-
Flagyl Microbiome in Crohn's Disease
NCT04682522 ·Status: COMPLETED ·Phase: PHASE4
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
NCT00304876 ·Status: COMPLETED
-
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
NCT04043897 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal Calprotectin Level in Patients With Nosocomial Diarrhea
NCT04491799 ·Status: COMPLETED
-
OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
NCT03051204 ·Status: COMPLETED
-
Case-Control Study to Identify Risk Factors for Microscopic Colitis
NCT01928667 ·Status: COMPLETED
-
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
NCT05829109 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
NCT00366236 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
NCT04979832 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplant (FMT) for Pouchitis
NCT02428361 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
NCT05714566 ·Status: RECRUITING
-
Outcomes of Outpatients in an Gut Microbiota Clinic
NCT06845527 ·Status: RECRUITING
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis
NCT01973465 ·Status: UNKNOWN ·Phase: NA
-
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
NCT00304408 ·Status: COMPLETED
-
Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis
NCT03268213 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Gut Microbiota Changes After Fecal Microbiota Transplantation
NCT02557685 ·Status: UNKNOWN ·Phase: PHASE2